| Christina Lynn Crump, | |
|
147 Foxtail Dr, Saint Charles, MO 63303-1703 | |
| (314) 623-7611 | |
| (636) 949-6945 |
| Full Name | Christina Lynn Crump |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 147 Foxtail Dr, Saint Charles, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003198847 | NPI | - | NPPES |
| 043397 | Other | MO | BOARD OF PHARMACY LISCENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 043397 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christina Lynn Crump, 147 Foxtail Drive, Saint Charles, MO 63303 Ph: (314) 623-7611 | Christina Lynn Crump, 147 Foxtail Dr, Saint Charles, MO 63303-1703 Ph: (314) 623-7611 |
News Archive
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.
New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining.
Millions of people suffer from Parkinson's disease, a disorder of the nervous system that affects movement and worsens over time. As the world's population ages, it's estimated that the number of people with the disease will rise sharply. Yet despite several effective therapies that treat Parkinson's symptoms, nothing slows its progression.
Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The Company's lead product, JVS-100, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.
› Verified 4 days ago
Megan Mcvicar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3800 Elm St, Saint Charles, MO 63301 Phone: 636-724-6628 | |
Jeffrey Frank Allen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1780 Zumbehl Rd, Saint Charles, MO 63303 Phone: 636-723-1134 | |
Maria Maull, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1039 S Duchesne Dr, Saint Charles, MO 63301 Phone: 636-724-4848 | |
Dr. David N Maywright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 314-541-9482 | |
Brent Tackitt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1768 Winding Glen Dr, Saint Charles, MO 63303 Phone: 618-292-8476 | |
Michael Frederick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2855 Veterans Memorial Parkway, (pharmacy), Saint Charles, MO 63303 Phone: 636-925-1143 |